Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii

Abstract

This is the first report on the expression and production of nanobodies against Bap. Increasing trends of drug resistance have shifted the focus to the role of antibodies in diagnosis and treatment of human diseases. Similarities of the produced VHH to human VH, makes the role of this nanobody promising in immunotherapy.